- Home
- SPTN vs VSTM Comparison
SPTN vs VSTM Comparison
Compare SPTN & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- VSTM
- Stock Information
- Founded
- SPTN 1917
- VSTM 2010
- Country
- SPTN United States
- VSTM United States
- Employees
- SPTN N/A
- VSTM N/A
- Industry
- SPTN Food Distributors
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- VSTM Health Care
- Exchange
- SPTN Nasdaq
- VSTM Nasdaq
- Market Cap
- SPTN 596.4M
- VSTM 531.1M
- IPO Year
- SPTN N/A
- VSTM 2012
- Fundamental
- Price
- SPTN $26.82
- VSTM $9.25
- Analyst Decision
- SPTN Hold
- VSTM Strong Buy
- Analyst Count
- SPTN 1
- VSTM 8
- Target Price
- SPTN $26.90
- VSTM $12.43
- AVG Volume (30 Days)
- SPTN 728.9K
- VSTM 2.9M
- Earning Date
- SPTN 08-14-2025
- VSTM 08-07-2025
- Dividend Yield
- SPTN 3.28%
- VSTM N/A
- EPS Growth
- SPTN N/A
- VSTM N/A
- EPS
- SPTN N/A
- VSTM N/A
- Revenue
- SPTN $9,693,074,000.00
- VSTM $2,137,000.00
- Revenue This Year
- SPTN $6.07
- VSTM $86.06
- Revenue Next Year
- SPTN N/A
- VSTM $395.22
- P/E Ratio
- SPTN N/A
- VSTM N/A
- Revenue Growth
- SPTN 1.54
- VSTM N/A
- 52 Week Low
- SPTN $17.30
- VSTM $2.34
- 52 Week High
- SPTN $26.86
- VSTM $9.43
- Technical
- Relative Strength Index (RSI)
- SPTN 77.70
- VSTM 73.31
- Support Level
- SPTN $26.54
- VSTM $8.71
- Resistance Level
- SPTN $26.70
- VSTM $9.43
- Average True Range (ATR)
- SPTN 0.09
- VSTM 0.61
- MACD
- SPTN -0.05
- VSTM 0.08
- Stochastic Oscillator
- SPTN 91.43
- VSTM 90.95
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.